7791 - 7800 of 8620 Results
Title
Year
- Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration2019OPENTitle: Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 49End Page: 59Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.196Best OA location URL: https://doi.org/10.1016/j.jalz.2019.08.196Citation Count: 36
-
OPENTitle: A comparison of prediction approaches for identifying prodromal Parkinson diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 8Start Page: e0256592End Page: e0256592Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0256592Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0256592&type=printableCitation Count: 8
- Static magnetic field stimulation of the supplementary motor area modulates resting-state activity and motor behavior2019OPENTitle: Static magnetic field stimulation of the supplementary motor area modulates resting-state activity and motor behaviorJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-019-0643-8Best OA location URL: https://www.nature.com/articles/s42003-019-0643-8.pdfCitation Count: 37
- Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease2023OPENTitle: Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-45078-3Best OA location URL: https://www.nature.com/articles/s41598-023-45078-3.pdfCitation Count: 8
-
OPENTitle: Post hoc analysis of the Exenatide‐PD trial—Factors that predict responseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 49Issue #: 3Start Page: 410End Page: 421Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.14096Citation Count: 60
- Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study2021OPENTitle: Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.020Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.12.020Citation Count: 16
- Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium2011OPENTitle: Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortiumJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 307Issue #: 1-2Start Page: 22End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2011.05.031Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3155471Citation Count: 56
- CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkers2022OPENTitle: CSF ferritin in the clinicopathological progression of Alzheimer’s disease and associations with APOE and inflammation biomarkersJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 3Start Page: 211End Page: 219Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2022-330052Best OA location URL: https://jnnp.bmj.com/content/jnnp/94/3/211.full.pdfCitation Count: 16
- Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial Parkinsonism2022OPENTitle: Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2217End Page: 2225Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29197Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9669136Citation Count: 17
-
OPENTitle: Parkinson's disease prevalence in Fabry disease: A survey studyJournal Name: Molecular Genetics and Metabolism ReportsPublisher: Elsevier BVVol: 14Issue #:Start Page: 27End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymgmr.2017.10.013Best OA location URL: https://doi.org/10.1016/j.ymgmr.2017.10.013Citation Count: 39